RecruitingNCT07547215

Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion

An Open Label, Prospective, Multicenter, Single-Arm, Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion


Sponsor

PainTEQ, LLC

Enrollment

100 participants

Start Date

May 27, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to evaluate the real-world performance, safety and efficacy of the TRAQ System.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Bone Allograft for people with sacroiliac joint dysfunction and sacroiliac joint pain. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBone Allograft

The PainTEQ TRAQ™ Posterior SI Joint Implant is processed human bone tissue that has been precision milled from cortical and cancellous bone. The allograft pierces the SI joint cortices and provides a scaffold around which new bone can grow.


Locations(1)

Pain Institute of Southern Arizona

Tucson, Arizona, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07547215


Related Trials